← Leaderboards
Kevin Wiehe
Duke University
$11,369,637
Attributed
$11,369,637
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.2M · FY2019–25$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,369,637 · 4
By mechanism
P01$10,573,377 · 3
R56$796,260 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Barton F Haynes$531,570,874
- Tamar Mendelson$10,622,694
- Kevin Saunders$18,205,751
- Gregory D Sempowski$25,654,938
- Wilton B Williams$19,801,567
Others in their field
Other Emerging Leaders on “Antigens”
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$42,191,190
- Bala Raja · Luminostics, Inc.$28,624,460
- Hanjoon Ryu$28,519,898
- Thomas Denny · Duke University$22,999,550
- Jay Evans · University Of Montana$22,565,626
- Julie Ake · National Institute Of Allergy And Infectious Diseases$22,000,000
Research focus
AntigensNeutralizing AntibodyAntibodiesMutationVaccinesDesignVaccine DesignCell SurfaceVaccine DevelopmentViralHiv VaccineVariantVaccine CandidateBindingSiteAnimalsImmunizeComplexAnimal ModelEpitopesAntibody ResponseGenealogyMouse ModelEvolution
Grant awards (7)
Immunogen design to elicit polyclonal bNAb responses to the V3 glycan supersite$855,055
P01 · FY2025 · AI · contact PI
Immunogen design to elicit polyclonal bNAb responses to the V3 glycan supersite$885,499
P01 · FY2024 · AI · contact PI
Project 2: PanbetaCoV protein vaccine design$2,828,814
P01 · FY2023 · AI · contact PI
Immunogen design to elicit polyclonal bNAb responses to the V3 glycan supersite$885,500
P01 · FY2023 · AI · contact PI
Immunogen design to elicit polyclonal bNAb responses to the V3 glycan supersite$901,125
P01 · FY2022 · AI · contact PI
Project 2: PanbetaCoV protein vaccine design$4,217,384
P01 · FY2021 · AI · contact PI
Immunogen Design Strategies To Direct Hiv-1 Broadly Neutralizing Antibody Maturation By Probability-Based Targeting Of Critical Mutations$796,260
R56 · FY2019 · AI · contact PI